Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Samsung Extends its Medical Device Business in the European Market

By Nadia Liefsoens, MedImaging Regional Director
Posted on 18 Mar 2013
A new medical device brand, called Geo, is showing a company’s commitment to global health through innovative medical devices. More...
The Geo brand includes XGeo for digital radiography, UGeo for ultrasound diagnostic systems, and LabGeo for in vitro diagnostics.

Samsung Electronics Co., Ltd. (Suwon, South Korea) launched its medical brand Geo with Samsung Medison (Gangwon, South Korea) at the European Congress of Radiology (ECR) 2013, held in Vienna (Austria) during March 7-11, 2013. Samsung also presented its latest medical equipment and technologies with Samsung Medison.

“Samsung is committed to bringing a new wave of innovation to the radiology market in Europe with our newly established medical equipment brand,” said S. I. Cho, president and head of the health and medical equipment business at Samsung Electronics and CEO of Samsung Medison. “Samsung will continue to develop products that offer fast, accurate diagnosis to both doctors and patients.

Samsung Electronics’ digital radiography (DR) range provides high performance through panel detectors. Even with dose reduction, XGEeo GC80 still provides effective images and diagnosis, which are both critical for the health and safety of patients. The DR’s soft-handling technology allows users to move the device with low physical pressure even without a side-handle.

The upgraded Accuvix A30 ultrasound system features the single crystal transducer optimized for radiology. The single crystal probe (transducer) provides a wide bandwidth, which allows the user to utilize a wider range of frequencies, granting a better resolution and penetration. Furthermore, for the first time, Samsung Electronics presented portable computed tomography (CT) products from NeuroLogica (Danvers, MA, USA). The company was acquired by Samsung Electronics earlier in 2013.

Moreover, Samsung hosted a satellite symposium at the Congress regarding a new tool for detecting and diagnosing breast cancer, the ultrasound ElastoScan. Speakers discussed the technology within ElastoScan and its diagnostic capability to help detect breast cancer at an early stage and support surgery procedure.

Samsung Electronics Co., Ltd. is a global leader in technology. Samsung Medison is a leading global medical devices company. Founded in 1985, the company markets innovative medical devices including diagnostic ultrasound, digital X-ray, and blood analyzers, in 110 countries worldwide. The company has attracted global attention in the medical field with its R&D capabilities and advanced technologies. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating information technology (IT), image processing, semiconductor and communication technologies into medical devices.

Related Links:

Samsung Electronics
Samsung Medison





Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Electrolyte Analyzer
CBS-4000 (CBS-400)
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Graphical abstract (Pandya T, Zagorulya M, Leung MM, et al. Plasma signals of lung tumor promotion for molecular cancer prevention. Cell. 2026. doi:10.1016/j.cell.2026.05.005)

Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead

Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.